WILMINGTON, Del., June 5, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced the transmission of its Abbreviated New Drug ...
In June 2025 NRx filed an Abbreviated New Drug Application with the FDA for a preservative-free preparation of ketamine, demonstrating support for 3 year room temperature stability and sterility. NRx ...
Pacira (PCRX) BioSciences reported it has received a Paragraph IV Certification Notice Letter from The WhiteOak Group, a subsidiary of a small private Chinese company. WhiteOak has filed an ...
Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback